TY  - RPRT
TI  - Anifrolumab Treatment Leads to Rapid Reduction in Urinary Biomarkers of Intrarenal Inflammation in Lupus Nephritis: Results From the Phase 2 Randomized Trial.
AU  - Andrea Fava
AU  - Michelle Petri
AU  - Patrick G Gavin
AU  - Eszter Csomor
AU  - Philip Z Brohawn
AU  - Daniel Muthas
AU  - Adam Platt
AU  - Catharina Lindholm
AU  - Nicola Ferrari
PY  - 2026
DO  - 10.1002/art.70089
UR  - https://pubmed.ncbi.nlm.nih.gov/41663906/
ID  - 41663906
ER  -